A biotechnology company developing RNA technologies to shape the future of gene therapy
Shape Therapeutics has raised $112.0M in total funding. The most recent round was Grant. The last funding was announced in July 2026.
Shape Therapeutics's investors include New Enterprise Associates, Michael J. Fox Foundation, Decheng Capital, Mission BioCapital, Cherubic Ventures.
Shape Therapeutics is headquartered in Seattle, United States.
A biotechnology company developing RNA technologies to shape the future of gene therapy
Shape Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Shape Therapeutics — Funding & Investors." VCBacked, July 29, 2026, https://www.vcbacked.co/company/shape-therapeutics. Accessed September 12, 2026.
VCBacked. (2026). Shape Therapeutics — Funding & Investors. Retrieved September 12, 2026, from https://www.vcbacked.co/company/shape-therapeutics
{{cite web |title=Shape Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/shape-therapeutics |website=VCBacked |access-date=September 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated